Skip to main content

Tropheryma whipplei Infection (Whipple Disease) in the USA

Digestive Diseases and Sciences volume 64, pages 213–223 (2019)Cite this article

Abstract

Background

Whipple disease (WD) is an infection caused by the bacterium Tropheryma whipplei (TW). Few cases have been reported in the USA.

Aims

To report on the demographics, clinical manifestations, diagnostic findings, treatment, and outcomes of TW infection.

Methods

Cases of TW infection diagnosed from 1995 to 2010 were identified in three US referral centers and from 1995 to 2015 in one. Definite classic WD was defined by positive periodic acid-Schiff (PAS) staining and probable WD by specific positive TW polymerase chain reaction (PCR) of intestinal specimens. Localized infections were defined by a positive TW PCR result from samples of other tissues/body fluids.

Results

Among the 33 cases of TW infections, 27 (82%) were male. Median age at diagnosis was 53 years (range 11–75). Diagnosis was supported by a positive TW PCR in 29 (88%) and/or a positive PAS in 16 (48%) patients. Classic WD was the most frequent presentation (n = 18, 55%), with 14 definite and 4 probable cases. Localized infections (n = 15, 45%) affected the central nervous system (n = 7), joints (n = 4), heart (n = 2), eye (n = 1), and skeletal muscle (n = 1). Blood PCR was negative in 9 of 17 (53%) cases at diagnosis. Ceftriaxone intravenously followed by trimethoprim and sulfamethoxazole orally was the most common regimen (n = 23, 70%). Antibiotic therapy resulted in clinical response in 24 (73%).

Conclusions

TW infection can present as intestinal or localized disease. Negative small bowel PAS and PCR do not exclude the diagnosis of TW infection, and blood PCR is insensitive for active infection.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Paulley JW. Whipple’s disease, intestinal lipodystrophy. Gastroenterologia. 1949;75:32.

    CAS  PubMed  Google Scholar 

  2. Jones FA, Paulley JW. Intestinal lipodystrophy. Whipple’s disease. Lancet. 1949;1:214–217.

    CAS  Article  Google Scholar 

  3. Dutly F, Altwegg M. Whipple’s disease and “Tropheryma whippelii”. Clin Microbiol Rev. 2001;14:561–583.

    CAS  Article  Google Scholar 

  4. Bai JC, Mazure RM, Vazquez H, et al. Whipple’s disease. Clin Gastroenterol Hepatol. 2004;2:849–860.

    Article  Google Scholar 

  5. Paulley JW. A case of Whipple’s disease (intestinal lipodystrophy). Gastroenterology. 1952;22:128–133.

    CAS  PubMed  Google Scholar 

  6. Chears WC Jr, Ashworth CT. Electron microscopic study of the intestinal mucosa in Whipple’s disease. Demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology. 1961;41:129–138.

    PubMed  Google Scholar 

  7. Feurle GE, Volk B, Waldherr R. Cerebral Whipple’s disease with negative jejunal histology. N Engl J Med. 1979;300:907–908.

    CAS  Article  Google Scholar 

  8. Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple’s-disease-associated bacterium. Lancet. 1991;338:474–475.

    CAS  Article  Google Scholar 

  9. Dobbins WO 3rd. The diagnosis of Whipple’s disease. N Engl J Med. 1995;332:390–392.

    Article  Google Scholar 

  10. Muller C, Stain C, Burghuber O. Tropheryma whippelii in peripheral blood mononuclear cells and cells of pleural effusion. Lancet. 1993;341:701.

    CAS  Article  Google Scholar 

  11. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;327:293–301.

    CAS  Article  Google Scholar 

  12. Elkins C, Shuman TA, Pirolo JS. Cardiac Whipple’s disease without digestive symptoms. Ann Thorac Surg. 1999;67:250–251.

    CAS  Article  Google Scholar 

  13. Greub G. A new piece added to the whipple puzzle: Tropheryma Whipplei primary infection with bacteremia and cough. Clin Infect Dis. 2010;51:522–524.

    Article  Google Scholar 

  14. Gabus V, Grenak-Degoumois Z, Jeanneret S, Rakotoarimanana R, Greub G, Genne D. Tropheryma whipplei tricuspid endocarditis: a case report and review of the literature. J Med Case Rep. 2010;4:245.

    Article  Google Scholar 

  15. Ramzan NN, Loftus E Jr, Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med. 1997;126:520–527.

    CAS  Article  Google Scholar 

  16. Bruhlmann P, Michel BA, Altwegg M. Diagnosis and therapy monitoring of Whipple’s arthritis by polymerase chain reaction. Rheumatology (Oxford). 2000;39:1427–1428.

    CAS  Article  Google Scholar 

  17. Fenollar F, Fournier P-E, Robert C, Raoult D. Use of Genome Selected Repeated Sequences Increases the Sensitivity of PCR Detection of Tropheryma whipplei. J Clin Microbiol. 2004;42:401–403.

    CAS  Article  Google Scholar 

  18. Keita AK, Bassene H, Tall A, et al. Tropheryma whipplei: a common bacterium in rural Senegal. PLoS Negl Trop Dis. 2011;5:e1403.

    Article  Google Scholar 

  19. Li W, Fenollar F, Rolain JM, et al. Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology. 2008;154:521–527.

    CAS  Article  Google Scholar 

  20. Qin S, Clausen E, Lucht L, et al. Presence of Tropheryma whipplei in different body sites in a cohort of healthy subjects. Am J Respir Criti Care Med. 2016;194:243–245.

    CAS  Article  Google Scholar 

  21. Martinetti M, Biagi F, Badulli C, et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology. 2009;136:2289–2294.

    CAS  Article  Google Scholar 

  22. Fleming JL, Wiesner RH, Shorter RG. Whipple’s disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63:539–551.

    CAS  Article  Google Scholar 

  23. Desnues B, Al Moussawi K, Fenollar F. New insights into Whipple’s disease and Tropheryma whipplei infections. Microbes Infect. 2010;12:1102–1110.

    Article  Google Scholar 

  24. Arnold CA, Moreira RK, Lam-Himlin D, De Petris G, Montgomery E. Whipple disease a century after the initial description: increased recognition of unusual presentations, autoimmune comorbidities, and therapy effects. Am J Surg Pathol. 2012;36:1066–1073.

    Article  Google Scholar 

  25. Fenollar F, Puechal X, Raoult D. Whipple’s disease. N Engl J Med. 2007;356:55–66.

    CAS  Article  Google Scholar 

  26. Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89:337–345.

    Article  Google Scholar 

  27. Fenollar F, Lagier JC, Raoult D. Tropheryma whipplei and Whipple’s disease. J Infect. 2014;69:103–112.

    Article  Google Scholar 

  28. Fenollar F, Raoult D. Whipple’s Disease. Clin Vaccin Immunol. 2001;8:1–8.

    CAS  Article  Google Scholar 

  29. Dolmans R, Boel C, Lacle M, Kusters J. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev. 2017;30:529–555.

    CAS  Article  Google Scholar 

  30. Morgenegg S, Dutly F, Altwegg M. Cloning and sequencing of a part of the heat shock protein 65 gene (hsp65) of “Tropheryma whippleii” and its use for detection of “T. whippleii” in clinical specimens by PCR. J Clin Microbiol. 2000;38:2248–2253.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Feurle GE, Moos V, Schinnerling K, et al. The immune reconstitution inflammatory syndrome in whipple disease: a cohort study. Ann Intern Med. 2010;153:710–717.

    Article  Google Scholar 

  32. Gunther U, Moos V, Offenmuller G, et al. Gastrointestinal diagnosis of classical whipple disease: clinical, endoscopic, and histophatologic features in 191 patients. Medicine (Baltimore). 2015;94:e714.

    Article  Google Scholar 

  33. Muller SA, Vogt P, Altwegg M, Seebach JD. Deadly Carousel or difficult interpretation of new diagnostic tools for Whipple’s disease: case report and review of the literature. Infection. 2005;33:39–42.

    CAS  Article  Google Scholar 

  34. Baisden BL, Lepidi H, Raoult D, Argani P, Yardley JH, Dumler JS. Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol. 2002;118:742–748.

    CAS  Article  Google Scholar 

  35. Edouard S, Fennolar F, Raoult D. The rise of Tropheryma whipplei: a 12-year retrospective study of PCR diagnoses in our reference center. J Clin Microbiol. 2012;50:3917–3920.

    Article  Google Scholar 

  36. Rolain J-M, Fenollar F, Raoult D. False positive PCR detection of Tropheryma whipplei in the saliva of healthy people. BMC Microbiol. 2007;7:48.

    Article  Google Scholar 

  37. Fenollar F, Laouira S, Lepidi H, Rolain J-M, Raoult D. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis. 2008;47:659–667.

    Article  Google Scholar 

  38. Compain C, Sacre K, Puéchal X, et al. Central nervous system involvement in Whipple Disease: clinical study of 18 patients and long-term follow-up. Medicine (Baltimore). 2013;92:324–330.

    Google Scholar 

  39. Keinath RD, Merrell DE, Vlietstra R, Dobbins WO 3rd. Antibiotic treatment and relapse in Whipple’s disease. Long-term follow-up of 88 patients. Gastroenterology. 1985;88:1867–1873.

    CAS  Article  Google Scholar 

  40. Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple’s Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci. 1994;39:1642–1648.

    CAS  Article  Google Scholar 

  41. Ryser RJ, Locksley RM, Eng SC, Dobbins WO 3rd, Schoenknecht FD, Rubin CE. Reversal of dementia associated with Whipple’s disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Gastroenterology. 1984;86:745–752.

    CAS  PubMed  Google Scholar 

  42. Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology. 2010;138:478–486. quiz 411–472.

    CAS  Article  Google Scholar 

  43. Lagier JC, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2014;69:219–227.

    CAS  Article  Google Scholar 

  44. Emonet S, Wuillemin T, Harbarth S, et al. Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline. Int J Infect Dis. 2015;30:17–19.

    CAS  Article  Google Scholar 

  45. Fenollar F, Perreal C, Raoult D. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro. Int J Antimicrob Agents. 2014;43:388–390.

    CAS  Article  Google Scholar 

  46. Lagier JC, Fenollar F, Lepidi H, Raoult D. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple’s disease. J Antimicrob Chemother. 2010;65:2005–2012.

    CAS  Article  Google Scholar 

  47. Boulos A, Rolain J-M, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother. 2004;48:747–752.

    CAS  Article  Google Scholar 

  48. Lagier JC, Fenollar F, Lepidi H, Raoult D. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple’s disease. J Antimicrob Chemother. 2011;66:1188–1189.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Division of Internal Medicine, Mayo Clinic, Rochester, MN, USA

    Isabel A. Hujoel

  2. Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, S.W., Rochester, MN, 55905, USA

    David H. Johnson, Joseph A. Murray & Alberto Rubio-Tapia

  3. Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY, USA

    Benjamin Lebwohl

  4. Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Daniel Leffler

  5. Division of Gastroenterology and Hepatology, University of Chicago, Chicago, IL, USA

    Sonia Kupfer

  6. Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA

    Tsung-Teh Wu

Authors
  1. Isabel A. Hujoel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David H. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamin Lebwohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Leffler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sonia Kupfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tsung-Teh Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joseph A. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alberto Rubio-Tapia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto Rubio-Tapia.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hujoel, I.A., Johnson, D.H., Lebwohl, B. et al. Tropheryma whipplei Infection (Whipple Disease) in the USA. Dig Dis Sci 64, 213–223 (2019). https://doi.org/10.1007/s10620-018-5033-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-5033-4

Keywords

  • Whipple disease
  • Intestinal lipodystrophy
  • Tropheryma
  • Malabsorption syndromes